ZMAT1 Promotes Osteoclastogenesis Through TRIM46 Mediated YAP1 Degradation and Inhibits Osteoblastogenesis
Advanced Science · 2026
DOI: 10.1002/advs.202521783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xinyu Chang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatic Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Osteoblasts, Osteogenesis, Osteoclasts, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission Smart Healthcare Project, Shanghai Science and Technology Innovation Action Plan.
Abstract (Originalsprache)
Osteoclasts and osteoblasts play critical roles in bone remodeling, and their dysregulation leads to pathological bone loss. However, the precise mechanisms underlying the regulation of differentiation remain unclear. This study investigated the role of the transcriptional regulator Zinc Finger Matrin‐Type 1 ( Zmat1 ) in both osteoclastogenesis and osteoblastogenesis. Zmat1 deficiency resulted in decreased osteoclast activity, and bone resorption. Mechanistically, ZMAT1 was significantly upregulated during osteoclast differentiation and acted as a transcriptional repressor of the E3 ubiquitin ligase TRIM46, which regulates YAP1 degradation via K48‐linked ubiquitination. Furthermore, Zmat1 deficiency enhanced osteoblast activity and bone formation. These findings highlight a novel ZMAT1/TRIM46/YAP1 axis, providing new insights into the transcriptional regulation of both osteoclast and osteoblast differentiation, and present potential therapeutic targets for osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traumatic Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, China.
- National Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China.
ORCID-Profile: Hao Zhang
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission Smart Healthcare Project
- Shanghai Science and Technology Innovation Action Plan
Zitieren
APA
Chang, X., Hou, Y., Cui, L., Yu, H., Liu, R., Sui, J., Zheng, Z., Liu, L., Chen, J., Chen, M., Ding, C., Xu, S., Xu, S., & Zhang, H. (2026). ZMAT1 Promotes Osteoclastogenesis Through TRIM46 Mediated YAP1 Degradation and Inhibits Osteoblastogenesis. Advanced Science. https://doi.org/10.1002/advs.202521783
Vancouver
Chang X, Hou Y, Cui L, Yu H, Liu R, Sui J, et al. ZMAT1 Promotes Osteoclastogenesis Through TRIM46 Mediated YAP1 Degradation and Inhibits Osteoblastogenesis. Advanced Science. 2026. doi:10.1002/advs.202521783
BibTeX
@article{Chang2026,
author = {Chang, Xinyu and Hou, Yijin and Cui, Likun and Yu, Huiqi and Liu, Rong and Sui, Junhao and Zheng, Zhong and Liu, Lu and Chen, Jie and Chen, Mengchen and Ding, Chen and Xu, Shuogui and Xu, Sheng and Zhang, Hao},
title = {ZMAT1 Promotes Osteoclastogenesis Through TRIM46 Mediated YAP1 Degradation and Inhibits Osteoblastogenesis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202521783}
}
EUVIMED